You are leaving Evergreentgn.com

You have clicked on an external link and will be taken offsite.

Lantheus has completed its acquisition of Evergreen Theragnostics, Inc. Please see the press release to learn more.

CDMO Pipeline Therapeutic Areas

Menu

About us Facilities News Careers

CDMO Pipeline Therapeutic Areas About us Facilities News Careers

menu

Close

CDMO Products & Pipeline Therapeutic Areas

Menu

About us Facilities News Careers

CDMO Products & Pipeline Therapeutic Areas About us Facilities News Careers

menu

Improving the options for cancer patients through theragnostic radiopharmaceuticals